Found: 23
Select item for more details and to access through your institution.
Standardization of Molecular MRD Levels in AML Using an Integral Vector Bearing ABL and the Mutation of Interest.
- Published in:
- Cancers, 2023, v. 15, n. 22, p. 5360, doi. 10.3390/cancers15225360
- By:
- Publication type:
- Article
Venetoclax‐based salvage therapy for adult patients with relapsed/refractory acute lymphoblastic leukemia.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 3, p. 365, doi. 10.1111/ejh.14015
- By:
- Publication type:
- Article
Clonal Myeloid Dysplasia Following CAR T-Cell Therapy: Chicken or the Egg?
- Published in:
- Cancers, 2023, v. 15, n. 13, p. 3471, doi. 10.3390/cancers15133471
- By:
- Publication type:
- Article
Risk factors and outcomes of COVID‐19 in adult patients with hematological malignancies: A single‐center study showing lower than expected rates of hospitalization and mortality.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 1, p. 135, doi. 10.1111/ejh.13977
- By:
- Publication type:
- Article
Desensitization protocol to lenalidomide: An effective and safe treatment modality for delayed hypersensitivity‐induced rash in patients with multiple myeloma.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 4, p. 407, doi. 10.1111/ejh.13918
- By:
- Publication type:
- Article
Monitoring Minimal Residual Disease in RUNX1-Mutated Acute Myeloid Leukemia.
- Published in:
- Acta Haematologica, 2022, v. 145, n. 6, p. 642, doi. 10.1159/000526353
- By:
- Publication type:
- Article
The Emerging Role of Venetoclax-Based Treatments in Acute Lymphoblastic Leukemia.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 18, p. N.PAG, doi. 10.3390/ijms231810957
- By:
- Publication type:
- Article
Gilteritinib monotherapy for relapsed/refractory FLT3 mutated acute myeloid leukemia: a real-world, multi-center, matched analysis.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 9, p. 2001, doi. 10.1007/s00277-022-04895-8
- By:
- Publication type:
- Article
Correction to: Gilteritinib monotherapy for relapsed/refractory FLT3 mutated acute myeloid leukemia: a real‑world, multi‑center, matched analysis.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Venetoclax in combination with FLAG-IDA-based protocol for patients with acute myeloid leukemia: a real-world analysis.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 8, p. 1719, doi. 10.1007/s00277-022-04883-y
- By:
- Publication type:
- Article
Polatuzumab-based regimen or CAR T cell for patients with refractory/relapsed DLBCL-a matched cohort analysis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Gene expression changes in male and female rhesus macaque 60 days after irradiation.
- Published in:
- PLoS ONE, 2021, v. 16, n. 7, p. 1, doi. 10.1371/journal.pone.0254344
- By:
- Publication type:
- Article
Less is more: reducing the number of administered chimeric antigen receptor T cells in a mouse model using a mathematically guided approach.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 7, p. 1165, doi. 10.1007/s00262-020-02516-9
- By:
- Publication type:
- Article
Optimization of Interferon–Alpha and Imatinib Combination Therapy for Chronic Myeloid Leukemia: A Modeling Approach.
- Published in:
- Advanced Theory & Simulations, 2019, v. 2, n. 1, p. N.PAG, doi. 10.1002/adts.201800081
- By:
- Publication type:
- Article
Daratumumab resistance is frequent in advanced‐stage multiple myeloma patients irrespective of CD38 expression and is related to dismal prognosis.
- Published in:
- European Journal of Haematology, 2018, v. 100, n. 5, p. 494, doi. 10.1111/ejh.13046
- By:
- Publication type:
- Article
Association of Hematological Nadirs and Survival in a Nonhuman Primate Model of Hematopoietic Syndrome of Acute Radiation Syndrome.
- Published in:
- Radiation Research, 2015, v. 184, n. 2, p. 226, doi. 10.1667/RR13962.1
- By:
- Publication type:
- Article
Recombinant interleukin-12, but not granulocyte-colony stimulating factor, improves survival in lethally irradiated nonhuman primates in the absence of supportive care: Evidence for the development of a frontline radiation medical countermeasure.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 9, p. 868, doi. 10.1002/ajh.23770
- By:
- Publication type:
- Article
Prediction of adverse events during intensive induction chemotherapy for acute myeloid leukemia or high-grade myelodysplastic syndromes.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 4, p. 423, doi. 10.1002/ajh.23661
- By:
- Publication type:
- Article
Randomized comparison of single dose of recombinant human IL-12 versus placebo for restoration of hematopoiesis and improved survival in rhesus monkeys exposed to lethal radiation.
- Published in:
- Journal of Hematology & Oncology, 2014, v. 7, n. 1, p. 1, doi. 10.1186/1756-8722-7-31
- By:
- Publication type:
- Article
Analyzing transformation of myelodysplastic syndrome to secondary acute myeloid leukemia using a large patient database.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 9, p. 853, doi. 10.1002/ajh.23257
- By:
- Publication type:
- Article
Targeted Drug Delivery by Gemtuzumab Ozogamicin: Mechanism-Based Mathematical Model for Treatment Strategy Improvement and Therapy Individualization.
- Published in:
- PLoS ONE, 2011, v. 6, n. 9, p. 1, doi. 10.1371/journal.pone.0024265
- By:
- Publication type:
- Article
Improving alloreactive CTL immunotherapy for malignant gliomas using a simulation model of their interactive dynamics.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 3, p. 425, doi. 10.1007/s00262-007-0387-z
- By:
- Publication type:
- Article
Improving alloreactive CTL immunotherapy for malignant gliomas using a simulation model of their interactive dynamics.
- Published in:
- 2008
- By:
- Publication type:
- Correction notice